TY - JOUR
T1 - Enzymatic hydrolysis allows an integral valorization of Nannochloropsis oceanica resulting in the production of bioactive peptide extracts and an eicosapentaenoic acid enriched fraction
AU - Cunha, Sara A.
AU - Coscueta, Ezequiel R.
AU - Alexandre, Agostinho M.R.C.
AU - Partidário, Ana Maria Carvalho
AU - Fernández, Naiara
AU - Paiva, Alexandre
AU - Silva, Joana Laranjeira
AU - Pintado, Manuela E.
N1 - Funding Information:
This research was funded by Fundo Europeu de Desenvolvimento Regional (FEDER), through the Programa Operacional Competitividade e Internacionalização (POCI) under the project VALORMAR: Valorização Integral dos recursos Marinhos: Potencial, Inovação Tecnológica e Novas Aplicações (POCI‐01‐0247‐FEDER‐024517); CBQF under the FCT project UIDB/50016/2020; and the individual FCT PhD research grant (ref. SFRH/BD/144155/2019) for the author Sara A. Cunha. This work was also funded by Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES, Portugal) through national funds to iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020) and the Associate Laboratory LS4FUTURE (LA/P/0087/2020). The authors acknowledge the financial support received from the Funding from INTERFACE Programme, through the Innovation, Technology and Circular Economy Fund (FITEC). The authors acknowledge AllMicroalgae (Pataias, Portugal) for the supply; and Aquitex for the enzymes supply. Nannochloropsis oceanica
Publisher Copyright:
© 2024 Wiley-VCH GmbH.
PY - 2024/1/19
Y1 - 2024/1/19
N2 - Nannochloropsis oceanica is a microalga with relevant protein content, making it a potential source of bioactive peptides. Furthermore, it is also rich in fatty acids, with a special focus on eicosapentaenoic acid (EPA), an omega-3 fatty acid mainly obtained from marine animal sources, with high importance for human health. N. oceanica has a rigid cell wall constraining protein extraction, thus hydrolyzing it may help increase its components’ extractability. Therefore, a Box–Behnken experimental design was carried out to optimize the hydrolysis. The hydrolysate A showed 67% ± 0.7% of protein, antioxidant activity of 1166 ± 63.7 μmol TE g−1 of protein and an ACE inhibition with an IC50 of 379 μg protein mL−1. The hydrolysate B showed 60% ± 1.8% of protein, antioxidant activity of 775 ± 13.0 μmol TE g−1 of protein and an ACE inhibition with an IC50 of 239 μg protein mL−1. The by-product showed higher yields of total fatty acids when compared to “raw” microalgae, being 5.22% and 1%, respectively. The sustainable developed methodology led to the production of one fraction rich in bioactive peptides and another with interesting EPA content, both with value-added properties with potential to be commercialized as ingredients for different industrial applications, such as functional food, supplements, or cosmetic formulations.
AB - Nannochloropsis oceanica is a microalga with relevant protein content, making it a potential source of bioactive peptides. Furthermore, it is also rich in fatty acids, with a special focus on eicosapentaenoic acid (EPA), an omega-3 fatty acid mainly obtained from marine animal sources, with high importance for human health. N. oceanica has a rigid cell wall constraining protein extraction, thus hydrolyzing it may help increase its components’ extractability. Therefore, a Box–Behnken experimental design was carried out to optimize the hydrolysis. The hydrolysate A showed 67% ± 0.7% of protein, antioxidant activity of 1166 ± 63.7 μmol TE g−1 of protein and an ACE inhibition with an IC50 of 379 μg protein mL−1. The hydrolysate B showed 60% ± 1.8% of protein, antioxidant activity of 775 ± 13.0 μmol TE g−1 of protein and an ACE inhibition with an IC50 of 239 μg protein mL−1. The by-product showed higher yields of total fatty acids when compared to “raw” microalgae, being 5.22% and 1%, respectively. The sustainable developed methodology led to the production of one fraction rich in bioactive peptides and another with interesting EPA content, both with value-added properties with potential to be commercialized as ingredients for different industrial applications, such as functional food, supplements, or cosmetic formulations.
KW - bioactive peptides
KW - eicosapentaenoic acid
KW - functional foods
KW - marine hydrolysates
KW - microalgae
KW - sustainability
UR - http://www.scopus.com/inward/record.url?scp=85185340645&partnerID=8YFLogxK
U2 - 10.1002/biot.202300291
DO - 10.1002/biot.202300291
M3 - Article
C2 - 38013664
AN - SCOPUS:85185340645
SN - 1860-6768
VL - 19
JO - Biotechnology Journal
JF - Biotechnology Journal
IS - 2
M1 - 2300291
ER -